19 November 2020
Vaccines Webinar: Infection and (Presymptomatic) Transmission of SARS-CoV-2—4 December 2020

SARS-CoV-2 is the newly identified human coronavirus that emerged in December 2019, resulting in severe respiratory disease and viral pneumonia. The disease was later named COVID-19 and has resulted in thousands of deaths to date. Research is underway to understand the transmission and pathogenicity, and to develop treatments and preventative measures for this serious illness. This webinar will discuss the latest advances in understanding the spread of SARS-CoV-2 and its pathogenicity, and will highlight the progress in vaccine and antiviral drug development.

Date: 4 December 2020

Time: 2pm (CET) | 8am (EDT) | 9pm (CST Asia)

Webinar ID: 868 8022 2663

Register for Free Here:



Dr. Hatem Elshabrawy

Guest Editor of “Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19

Interests: Development of antiviral small molecules and antibodies



Dr. Francesco De Sanctis

Presentation: " Deciphering the state of immune silence in fatal COVID-19 patients""


Prof. Maria Anagnostouli

Presentation: " Host HLA-genotype and COVID-19 infection. Impact on severity, clinical outcome and therapeutics "


Dr. Hussin Rothan

Presentation: "The widespread of SARS-CoV-2 virus could be attributed to the genetic variation in the viral spikes"


Dr. Kathleen L. Hefferon

Presentation: "Using Plants to Fight COVID-19"

For any questions about the webinar, please send an email to [email protected].

More News...
Back to TopTop